Have a personal or library account? Click to login
Post-treatment surveillance in colorectal cancer Cover

Post-treatment surveillance in colorectal cancer

By: Vaneja Velenik  
Open Access
|May 2010

References

  1. Cancer incidence in Slovenia 2006. Report no. 48. Ljubljana: Institute of Oncology Ljubljana, Cancer Registry of Republic of Slovenia; 2009.
  2. Primic Žakelj M, Zadnik V, Žagar T, Zakotnik B. Survival of cancer patients, diagnosed in 1991-2005 in Slovenia. Ljubljana: Institute of Oncology Ljubljana, Cancer Registry of Republic of Slovenia; 2009.
  3. Goldberg RM, Fleming TR, Tangen CM, Moertel CG, Macdonald JS, Haller DG, et al. Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Ann Intern Med 1998; 129: 27-35.10.7326/0003-4819-129-1-199807010-00007
  4. Velenik V. Locally recurrent rectal cancer: treatment options. Radiol Oncol 2009; 43: 144-51.10.2478/v10019-009-0028-6
  5. Cali RL, Pitsch RM, Thorson AG, Watson P, Tapia P, Blatchford GJ, et al. Cumulative incidence of metachronous colorectal cancer. Dis Colon Rectum 1993; 36: 388-93.10.1007/BF02053945
  6. Enblad P, Adami HO, Glimelius B, Krusemo U, Pahlman L. The risk of subsequent primary malignant diseases after cancers of the colon and rectum. A nationwide cohort study. Cancer 1990; 65: 2091-100.10.1002/1097-0142(19900501)65:9<;2091::AID-CNCR2820650934>3.0.CO;2-M
  7. Bulow S, Svendsen LB, Mellemgaard A. Metachronous colorectal carcinoma. Br J Surg 1990; 77: 502-5.10.1002/bjs.1800770509
  8. Evans HS, Moller H, Robinson D, Lewis CM, Bell CMJ, Hodgson SV. The risk of subsequent primary cancers after colorectal cancer in southeast England. Gut 2001; 50: 647-52.10.1136/gut.50.5.647
  9. Shureiqi I, Coaksley CD, Morris J, Soliman AS, Levin B, Lippman SM.: Effect of age on risk of second primary colorectal cancer. J Natl Cancer Inst 2001; 93: 1264-6.10.1093/jnci/93.16.1264
  10. Green RJ, Metlay JP, Propert K, Catalano PJ, Mayer RJ, Haller DG. Surveillance for second primary colorectal cancer after adjuvant chemotherapy: an analysis of Intergroup 0089. Ann Int Med 2002; 136: 261-9.10.7326/0003-4819-136-4-200202190-00005
  11. Birgisson H, Pĺhlman L, Gunnarsson U, Glimelius B. Occurrence of second cancers in patients treated with radiotherapy for rectal cancer. J Clin Oncol 2005; 23: 6126-31.10.1200/JCO.2005.02.543
  12. Goldberg RM, Fleming TR, Tangen CM, Moertel CG, Macdonald JS, Haller DG, et al. Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group. Ann Intern Med 1998; 129: 27-35.10.7326/0003-4819-129-1-199807010-00007
  13. Anthony T, Fleming JB, Bieligk SC, Sarosi GA, Kim LT, Gregorcyk SG, et al. Postoperative colorectal cancer surveillance. J Am Coll Surg 2000; 190: 737-49.10.1016/S1072-7515(99)00298-7
  14. Korner H, Soreide K, Stokkeland PJ, Soreide JA. Systematic follow-up after curative surgery for colorectal cancer in Norway: a population-based audit of effectiveness, costs, and compliance. J Gastrointest Sur 2005; 9: 320-8.10.1016/j.gassur.2004.09.023
  15. Turk PS, Wanebo HJ. Results of surgical treatment of nonhepatic recurrence of colorectal carcinoma. Cancer 1993; 71(Suppl 12): 4267-77.10.1002/1097-0142(19930615)71:12+<;4267::AID-CNCR2820711816>3.0.CO;2-O
  16. Perše M, Cerar A. Physical activity and colorectal cancer. [Slovenian]. Zdrav Vestn 2009; 78: 399-405.
  17. Makela JT, Laitinen SO, Kairaluoma MI. Five-year follow-up after radical surgery for colorectal cancer. Results of a prospective randomized trial. Arch Surg 1995; 130: 1062-7.10.1001/archsurg.1995.01430100040009
  18. Ohlsson B, Breland U, Ekberg H, Graffner H, Trannberg KG. Follow- up after curative surgery for colorectal carcinoma. Randomized comparison with no follow-up. Dis Colon Rectum 1995; 38: 619-26.10.1007/BF02054122
  19. Kjeldsen BJ, Kronborg O, Fenger C, Jřrgensen OD. A prospective randomized study of follow-up after radical surgery for colorectal cancer. Br J Surg 1997; 84: 666-9.
  20. Schoemaker D, Black R, Giles L, Toouli J. Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survival of colorectal cancer patients. Gastroenterology 1998; 114: 7-14.10.1016/S0016-5085(98)70626-2
  21. Pietra N, Sarli L, Costi R, Ouchemi C, Grattarola M, Peracchia A. Role of follow-up in management of local recurrences of colorectal cancer. Dis Colon Rectum 1998, 41: 1127-33.10.1007/BF02239434
  22. Secco GB, Fardelli R, Gianquinto D, Bonfante P, Baldi E, Ravera G, et al. Efficacy and cost of risk-adapted follow up in patients after colorectal cancer surgery: a prospective, randomized and controlled trial. Eur J Surg Oncol 2002, 28: 418-23.10.1053/ejso.2001.1250
  23. Kovač V, Smrdel U. Meta-analyses of clinical trials in patients with non-small cell lung cancer. Neoplasma 2004; 51: 334-40.
  24. Renehan AG, Egger M, Saunders MP, O'Dwyer ST. Impact on survival of intense follow-up after curative resection of colorectal cancer: systematic review and meta-analysis of randomized trials. Brit Med J 2002, 324: 1-8.10.1136/bmj.324.7341.813
  25. Jeffery GM, Hickey BE, Hider P. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev 2002; 1: CD002200.10.1002/14651858.CD002200
  26. Figueredo A, Rumble RB, Maroun J, Earle CC, Cummings B, McLeod R, et al. Follow-up of patients with curatively resected colorectal cancer: a practice guideline. BMC Cancer 2003; 3: 26.10.1186/1471-2407-3-26
  27. Bruinvels DJ, Stiggelbout AM, Kievet J, van Houwelingen HC, Habbema JD, van de Velde CJ. Follow-up of patients with colorectal cancer: A meta-analysis. Ann Surg 1994; 219: 174-82.10.1097/00000658-199402000-00009
  28. Rosen M, Chan L, Beart RW, Anthone G. Follow-up of colorectal cancer: a meta-analysis. Dis Colon Rectum 1998; 41: 1116-26.10.1007/BF02239433
  29. Grossmanna EM, Johnsona FE, Virgoa KS, Longob WE, Fossatic R. Follow-up of colorectal cancer patients after resection with curative intent—the GILDA trial. Surg Oncol 2004; 13: 119-24.10.1016/j.suronc.2004.08.005
  30. Miklos M, Gajski G, Garaj-Vrhovac V. Usage of the standard and modified comet assay in assessment of DNA damage in human lymphocytes after exposure to ionizing radiation. Radiol Oncol 2009; 43: 97-107.10.2478/v10019-009-0015-y
  31. Kievit J. Follow-up of patients with colorectal cancer: numbers needed to test and treat. Eur J Cancer 2002; 38: 986-99.10.1016/S0959-8049(02)00061-8
  32. Stiggelbout AM, de Haes JC, Vree R, van der Velde CJ, Brujninckx CM, van Groningen K, et al. Follow-up of colorectal cancer patients: quality of life and attitudes towards follow-up. Br J Cancer 1997; 75: 914-20.10.1038/bjc.1997.16120633879062416
  33. Wattchow DA, Weller DP, Esterman A, Pilotto LS, McGorm K, Hammett Z, et al. General practice vs surgical-based follow-up for patients with colon cancer: randomised controlled trial. Br J Cancer 2006; 94: 1116-21.10.1038/sj.bjc.6603052236124516622437
  34. Kjeldsen BJ, Thorsen H, Whalley D, Kronborg O. Influence of follow-up on health-related quality of life after radical surgery for colorectal cancer. Scand J Gastroenterol 1999; 34: 509-15.10.1080/00365529975002625410423068
  35. Virgo KS, Vernava AM, Longo WE, McKirgan LW, Johnson FE. Cost of patient follow-up after potentially curative colorectal cancer treatment. JAMA 1995; 273: 1837-41.10.1001/jama.1995.03520470045030
  36. Audisio RA, Setti-Carraro P, Segala M, Capko D, Andreoni B, Tiberio G. Follow-up in colorectal cancer patients: a cost-benefit analysis. Ann Surg Oncol 1996; 3: 349-57.10.1007/BF023056648790847
  37. Zieren HU, Muller JM. After-care of gastrointestinal malignancies: an evaluation of costs and benefits. Zentralbl Chir 1996; 121: 167-76.
  38. Rodríguez-Moranta F, Saló J, Arcusa A, Boadas J, Piñol V, Bessa X, et al. Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: A prospective, multicenter, randomized, controlled trial. J Clinl Oncol 2006; 24: 386-93.10.1200/JCO.2005.02.082616365182
  39. Earle CC, Grunfeld E, Cripps MC, Stern HS. Cancer physicians' attitudes toward colorectal cancer follow-up. Ann Oncol 2003; 14: 400-5.10.1093/annonc/mdg10112598345
  40. Haggstrom D, Arora N, Oakley-Girvan I. Primary and subspecialty care models of follow-up care delivery among colorectal cancer survivors [Abstract]. J Clin Oncol 2008; 26(Suppl 1): Abstract 6540.10.1200/jco.2008.26.15_suppl.6540
  41. Snyder C, Earle C, Herbert R, Neville BA, Blackford AL, Frick KD. Trends in follow-up and preventive care for colorectal cancer survivors. J Gen Intern Med 2008; 23: 254-9.10.1007/s11606-007-0497-5235947518197456
  42. Snyder CF, Earle CC, Herbert RJ, Neville BA, Blackford AL, Frick KD. Preventive care for colorectal cancer survivors: a 5-year longitudinal study. J Clin Oncol 2008; 26:1073-9.10.1200/JCO.2007.11.985918309941
  43. Nissen MJ, Beran MS, Lee MW, Mehta SR, Pine DA, Swenson KK. Views of primary care physicians on follow-up care of cancer patients. Fam Med 2007; 39: 477-82.
  44. Institute of Medicine. From cancer patient to cancer survivor: lost in transition. Washington, DC: National Academy Press; 2005.
  45. Wattchow DA, Weller DP, Esterman A, Pilotto LS, McGorm K, Hammett Z, et al. General practice vs surgical-based follow- up for patients with colon cancer: randomised controlled trial. Br J Cancer 2006, 94: 1116-21.10.1038/sj.bjc.6603052236124516622437
  46. Ocvirk J. Advances in the treatment of metastatic colorectal carcinoma. Radiol Oncol 2009; 43: 1-8.10.2478/v10019-009-0004-1
  47. Desch CE, Benson AB 3rd, Somerfield MR, Flynn PJ, Krause C, Loprinzi CL, et al. Colorectal cancer surveillance. 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol 2005; 23: 8512-9.10.1200/JCO.2005.04.006316260687
  48. Engstrom PF, Arnoletti JP, Benson AB 3rd, Chen YJ, Choti MA, Cooper HS, et al. NCCN Clinical Practice Guidelines in Oncology: rectal cancer. J Natl Compr Canc Netw 2009; 7: 838-81.10.6004/jnccn.2009.005719755047
  49. Engstrom PF, Arnoletti JP, Benson AB 3rd, Chen YJ, Choti MA, Cooper HS, et al. NCCN Clinical Practice Guidelines in Oncology: colon cancer. J Natl Compr Canc Netw 2009; 7: 778-831.10.6004/jnccn.2009.0056
  50. Glimelius B, Oliveira J. Rectal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2009; 20 (Suppl 4): iv54-6.10.1093/annonc/mdp128
  51. Van Cutsem EJ, Oliveira J. Primary colon cancer: ESMO clinical recommendations for diagnosis, adjuvant treatment and follow-up. Ann Oncol 2009; 20 (Suppl 4): iv49-50.10.1093/annonc/mdp126
  52. Peeters KC, Marijnen CA, Nagtegaal ID, Kranenbarg EK, Putter H, Wiggers T, et al. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 2007; 246: 693-701.10.1097/01.sla.0000257358.56863.ce
  53. Collette L, Bosset JF, den Dulk M, Nguyen F, Mineur L, Maingon P, et al. Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the Europea. J Clin Oncol 2007; 25: 4379-86.10.1200/JCO.2007.11.9685
  54. Van Cutsem E, Dicato M, Haustermans K, Arber N, Bosset JF, Cunningham D, et al. The diagnosis and management of rectal cancer: expert discussion and recommendations derived from 9th World Congress on Gastrointestinal Cancer, Barcelona 2007. Ann Oncol 2008; 19 (Suppl 6): vi1-8.10.1093/annonc/mdn358
  55. Velenik V, Oblak I, Anderluh F. Quality of life in patients after combined modality treatment of rectal cancer: Report of a prospective phase II study. Radiol Oncol 2008; 42: 207-14.10.2478/v10019-008-0019-z
  56. Schneider EC, Malin JL, Kahn KL, Ko CY, Adams J, Epstein AM. Surviving colorectal cancer: patient-reported symptoms 4 years after diagnosis. Cancer 2007; 110: 2075-82.10.1002/cncr.23021
  57. Sprangers MAG, Taal BG, Aaronson NK, Velde A. Quality of life in colorectal cancer: stoma vs.nonstoma patients. Dis Colon Rectum 1995; 38: 361-9.10.1007/BF02054222
  58. Kalso E, Tasmuth T, Neuvanen PJ. Amitriptyline effectivelly relieves neuropatic pain following treatment of breast cancer. Pain 1996; 64: 293-302.10.1016/0304-3959(95)00138-7
  59. Baxter NN, Habermann EB, Tepper JE, Durham SB, Virnig BA. Risk of pelvic fractures in older women following pelvic irradiation. JAMA 2005; 294: 2587-93.10.1001/jama.294.20.258716304072
  60. Vernava AM 3rd, Longo WE, Virgo KS, Coplin MA, Wade TP, Johnson FE. Current follow-up strategies after resection of colon cancer. Results of a survey of members of the American Society of Colon and Rectal Surgeons. Dis Colon Rectum 1994; 37: 573-83.10.1007/BF020509938200237
  61. Giordano P, Efron J, Vernava AM III, Weiss EG, Nogueras JJ, Wexner SD. Strategies of follow-up for colorectal cancer: a survey of the American Society of Colon and Rectal Surgeons. Tech Coloproctol 2006; 10: 199-207.10.1007/s10151-006-0280-316969616
  62. Rolnick S, Hensley Alfors S, Kucera GP, Fortman K, Ulcickas Yood M, Jankowski M, et al. Racial and age differences in colon examination surveillance following a diagnosis of colorectal cancer. J Natl Caner Inst Monogr 2005; 96-101.10.1093/jncimonographs/lgi04516287893
  63. Cooper GS, Kou DT, Reynolds HL Jr. Receipt of guideline-recommended follow-up in older colorectal cancer survivors: a population-based analysis. Cancer 2008; 113: 2029-37.10.1002/cncr.2382318780338
DOI: https://doi.org/10.2478/v10019-010-0018-8 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 135 - 141
Published on: May 3, 2010
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2010 Vaneja Velenik, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.

Volume 44 (2010): Issue 3 (September 2010)